Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 4:17 pm Purchase |
2023-12-31 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
HarbourVest Partners L.P. | 3,512,110 6.400% |
865,051 (+32.68%) |
Filing History |
| 2023-07-21 08:00 am Purchase |
2023-07-11 | 13G | Evelo Biosciences, Inc. EVLO |
HarbourVest Partners L.P. | 1,451,876 8.800% |
1,451,876 (New Position) |
Filing History |
| 2023-02-14 06:10 am Unchanged |
2022-12-31 | 13G | Evelo Biosciences, Inc. EVLO |
HarbourVest Partners L.P. | 153,175 2.800% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:06 am Purchase |
2022-12-31 | 13G | Axcella Health Inc. AXLA |
HarbourVest Partners L.P. | 248,317 8.400% |
73,171 (+41.78%) |
Filing History |
| 2022-03-29 06:09 am Purchase |
2022-03-16 | 13G | Axcella Health Inc. AXLA |
HarbourVest Partners L.P. | 175,146 8.460% |
62,827 (+55.94%) |
Filing History |
| 2022-02-14 07:01 am Purchase |
2021-12-31 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
HarbourVest Partners L.P. | 2,647,059 5.500% |
2,647,059 (New Position) |
Filing History |
| 2021-02-16 08:08 am Purchase |
2020-12-31 | 13G | Axcella Health Inc. AXLA |
HarbourVest Partners L.P. | 112,319 7.500% |
63,158 (+128.47%) |
Filing History |
| 2021-02-16 08:00 am Purchase |
2020-12-31 | 13G | Kaleido Biosciences, Inc. KLDO |
HarbourVest Partners L.P. | 1,833,832 5.100% |
1,833,832 (New Position) |
Filing History |
| 2021-02-16 07:59 am Purchase |
2020-12-31 | 13G | Evelo Biosciences, Inc. EVLO |
HarbourVest Partners L.P. | 153,175 6.600% |
65,000 (+73.72%) |
Filing History |